We are live on !
Find out more
Biodexa Pharmaceuticals
BDRX
BDRX
hedge funds and large institutions have $45.8K invested in Biodexa Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
13.61% less ownership
Funds ownership: 17.15% → 3.54% (-14%)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $57.4K
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$21K |
| 2 |
Virtu Financial
New York
|
-$18K |
| 3 |
CVI Holdings
Wilmington,
Delaware
|
-$11.9K |
| 4 |
Kingsview Wealth Management
Grants Pass,
Oregon
|
-$6.49K |